Commonwealth Equity Services, LLC Fortress Biotech, Inc. Transaction History

Commonwealth Equity Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$0.28 - $0.65 $4,000 - $9,287	14,288 Added 76.46%	32,974 $10,000
Q2 2023 Aug 10, 2023	BUY	$0.49 - $0.82 $2,142 - $3,585	4,373 Added 30.55%	18,686 $10,000
Q1 2023 May 11, 2023	BUY	$0.65 - $1.1 $585 - $990	900 Added 6.71%	14,313 $11,000
Q3 2022 Nov 14, 2022	BUY	$0.79 - $22.0 $1,386 - $38,610	1,755 Added 15.05%	13,413 $11,000
Q2 2022 Jul 19, 2022	BUY	$0.8 - $1.5 $9,326 - $17,487	11,658 New	11,658 $9,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.